Regulatory Filing Strategies Adopted by Generic Companies
Bibliographic record
Abstract
Abstract This chapter outlines regulatory filing strategies used by generic pharmaceutical companies in Australia, Canada, China, India, Japan, Germany, Italy, the Netherlands, and the United Kingdom to obtain approval for their products. It explains that in Australia the innovator applies for the inclusion of its patent portfolio on the Australian Register of Therapeutic Goods (ARTG). In Canada, securing a notice of compliance (NOC) first offers a commercial advantage, while in China, early filing with the State Food and Drug Administration (SFDA) is advised due to the lengthy approval process. The chapter details how Japan’s process involves legal opinions of non-infringement, potential MMA approval delays by the Ministry of Health, Labour and Welfare (MHLW), and negotiation requirements if intellectual property issues arise. It discusses harmonised EU and EEC rules followed by Germany, the Netherlands, and the United Kingdom, and Italy’s simplified AIC procedure under Art 10 of Legislative Decree 219/2006.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.024 | 0.032 |
| Meta-epidemiology (narrow) | 0.001 | 0.001 |
| Meta-epidemiology (broad) | 0.000 | 0.001 |
| Bibliometrics | 0.007 | 0.004 |
| Science and technology studies | 0.004 | 0.004 |
| Scholarly communication | 0.015 | 0.006 |
| Open science | 0.003 | 0.003 |
| Research integrity | 0.005 | 0.005 |
| Insufficient payload (model declined to judge) | 0.015 | 0.005 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".